OTC Markets Stock News
All posts tagged "leronlimab"
-
10.9KBiotechRISE of the COVID-19 Therapeutics CytoDyn (OTCMKTS: CYDY) & Humanigen (NASDAQ:HGEN)
Enrollment Key Metric in Therapeutic Race Philippines EUA Relevant to CytoDyn, not Humanigen Highly Credentialed Humanigen Team Possibility of NASDAQ Uplisting for...
-
11.7KBiotechCytoDyn (OTCMKTS: CYDY) Subtly Signals Pivot Into Philippines and Vaccine Market
On Sunday Night CytoDyn Inc. (OTCMKTS:CYDY) quietly placed a link in their developing news section to a 2016 medical journal article that...
-
10.5KBiotechHandicapping CytoDyn’s (OTCMKTS: CYDY) Interim Readout
Powerful recommendation from DSMB Imminent on Leronlimab Numbers are not part of any Interim report unless a statistical penalty is taken A...
-
10.2K1BiotechAll Eyes On CytoDyn Now That Trump Has COVID-19
Just now, markets are waking up to the news that President Donald Trump and First Lady Melanie have tested positive for COVID-19....
-
24.2K1BiotechCytoDyn (OTCMKTS:CYDY) May Make the White House Podium
CytoDyn Inc. (OTCMKTS:CYDY) may be the target of a White House press briefing very soon. A couple of social media influencers like...
-
16.1K2BiotechWading through the STAT News FUD Attack on CytoDyn Inc. (OTCMKTS: CYDY)
CytoDyn Inc. (OTCMKTS: CYDY) announced superb top-line data in their mild to moderate COVID-19 phase 2 trial and did not disappoint; however,...
-
29.1K1BiotechCytoDyn’s (OTCMKTS: CYDY) Strong Safety Data in Mild to Moderate Smokes Gilead (NASDAQ: GILD) & Crushes Endpoint Leading to the First Potential COVID-19 Approval
CytoDyn Inc. (OTCMKTS: CYDY) announced groundbreaking safety results from its phase 2 Mild to Moderate COVID-19 trial today. The company reported a...
-
13.1K1BiotechCytoDyn (OTCMKTS: CYDY) Bolts Higher On Mexican Approval Chatter
Yesterday CytoDyn Inc. (OTCMKTS: CYDY) moved up 27% on the completion of a Memorandum of Understanding with the NIH of Mexico to...
-
11.5K1BiotechGilead (NASDAQ: GILD) Shares Jump On Trial Results and Fauci Despite 9.3% Mortality Rate After 14 Days
Today Gilead Sciences (NASDAQ: GILD) was making a splash about their phase 3 trial results but all this trial essentially did was...
-
26.1KBiotechUK Prime Minister Boris Johnson Linkage to CytoDyn (OTCMKTS: CYDY) Evolving
CytoDyn Inc. (OTCMKTS: CYDY) announced today it was collaborating with the United Kingdom’s Department of Health to provide emergency access to leronlimab...
